Advanced search
1 file | 194.43 KB

Propranolol as a novel treatment for congenital visceral haemangioma

(2010) NEONATOLOGY. 98(3). p.229-231
Author
Organization
Keywords
Newborn, Visceral haemangioma, Propranolol, CAPILLARY ENDOTHELIAL-CELLS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 194.43 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vanlander, Arnaud, Wim Decaluwe, Michel Vandelanotte, Chris Van Geet, and Luc Cornette. 2010. “Propranolol as a Novel Treatment for Congenital Visceral Haemangioma.” Neonatology 98 (3): 229–231.
APA
Vanlander, Arnaud, Decaluwe, W., Vandelanotte, M., Van Geet, C., & Cornette, L. (2010). Propranolol as a novel treatment for congenital visceral haemangioma. NEONATOLOGY, 98(3), 229–231.
Vancouver
1.
Vanlander A, Decaluwe W, Vandelanotte M, Van Geet C, Cornette L. Propranolol as a novel treatment for congenital visceral haemangioma. NEONATOLOGY. 2010;98(3):229–31.
MLA
Vanlander, Arnaud, Wim Decaluwe, Michel Vandelanotte, et al. “Propranolol as a Novel Treatment for Congenital Visceral Haemangioma.” NEONATOLOGY 98.3 (2010): 229–231. Print.
@article{3097404,
  author       = {Vanlander, Arnaud and Decaluwe, Wim and Vandelanotte, Michel and Van Geet, Chris and Cornette, Luc},
  issn         = {1661-7800},
  journal      = {NEONATOLOGY},
  keyword      = {Newborn,Visceral haemangioma,Propranolol,CAPILLARY ENDOTHELIAL-CELLS},
  language     = {eng},
  number       = {3},
  pages        = {229--231},
  title        = {Propranolol as a novel treatment for congenital visceral haemangioma},
  url          = {http://dx.doi.org/10.1159/000291300},
  volume       = {98},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: